About Resilient Biotics
Resilient Biotics is a private company based in Research Triangle Park, North Carolina. It has reported $11,034,432 raised in two offerings on Form D since December 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 16, 2022 | Aug 19, 2022amended Dec 12, 2024 | $3,862,000of $4.6M target | 6 | $643K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Dec 2, 2020 | Dec 15, 2020 | $7,172,432fully sold | 18 | $398K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $11,034,432 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Resilient Biotics's Form D filed Dec 12, 2024.
EE
Eric Eason
Director
JP
John Peryam
Director
RG
Rachelle Galvin
President and director
DL
Drew Lanza
Director
CB
Christopher Belnap
Executive officer and director
Earlier filings also listed Greg Werner (executive officer and director, last listed Dec 2020).